Search

Your search keyword '"Notarangelo, L.D."' showing total 76 results

Search Constraints

Start Over You searched for: Author "Notarangelo, L.D." Remove constraint Author: "Notarangelo, L.D."
76 results on '"Notarangelo, L.D."'

Search Results

1. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)

2. A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

4. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

5. The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic Countries

6. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

7. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

10. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency

12. Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

13. Editorial Acknowledgment

14. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

17. Cut and paste: Using CRISPR/Cas9 to model RAG1 deficiency

19. Introduction on primary immunodeficiency diseases

20. Human PI4KIIIa lipid kinase complex

21. Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint

22. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity

23. B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients

24. Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells

25. Primary Immune Deficiency Treatment Consortium (PIDTC) report

26. Studio prospettico di 53 pazienti con sindrome di Wiskott Aldrich e piastrinopenia X-recessiva :risultati dell'applicazione delle raccomandazioni AIEOP per WAS/XLT

28. Risultati dell'applicazione delle raccomandazioni AIEOP per l'agammaglobulinemia X-recessiva

29. CARATTERISTICHE CLINICO - IMMUNOLOGICHE DI 50 PAZIENTI CON SINDROME DI WISKOTT ALDRICH E PIASTRINOPENIA X-RECESSIVA:RISULTATI DELLE RACCOMANDAZIONI DIAGNOSTICO TERAPEUTICHE WAS-XLT AIEOP

30. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells

31. Hypomorphic Rag1mutations alter the preimmune repertoire at early stages of lymphoid development

32. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation

37. Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells

41. Acute inflammatory demyelinating polyradiculoneuropathy associated with perforin-deficient familial haemophagocytic lymphohistiocytosis.

42. Elective bone marrow transplantation in a child with X-linked hyper-IgM syndrome presenting with acute respiratory distress syndrome.

43. B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency.

44. X-linked immunodeficiency with hyper-IgM (XHIM).

48. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

49. Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study

50. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Catalog

Books, media, physical & digital resources